#Artificial Tendons and Ligaments Market 2019
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
Tumblr Inc. has $15.1M in annual revenue.
Text
Introduction to Artificial Tendons and Ligaments: A Breakthrough in Medical Technology
The global artificial tendons and ligaments market size reached USD 1.86 Billion in 2022 and is expected to register a revenue CAGR of 13.6% during the forecast period, according to latest analysis by Emergen Research. Sports-related injuries are becoming ever-more common, and this is a key factor driving market revenue growth. Rise in medical expenditure is also being driven by the increasing number of traffic accidents in various countries around the world.
The global Artificial Tendons and Ligaments market report is a methodical research of the Artificial Tendons and Ligaments market done by extensive primary and secondary research. The fundamental purpose of the Artificial Tendons and Ligaments market report is to offer an accurate and strategic analysis of the Artificial Tendons and Ligaments business sphere.
Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/1808
Competitive Terrain:
The global Artificial Tendons and Ligaments industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.
The leading market contenders listed in the report are:
Neoligaments; Orthomed S.A.S.; Corin Group; Arthrex Inc.; HLL Lifecare Limited; Mathys AG Bettlach; FH Orthopedics
Key market aspects studied in the report:
Market Scope: The report explains the scope of various commercial possibilities in the global Artificial Tendons and Ligaments market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.
Competitive Outlook: The leading companies operating in the Artificial Tendons and Ligaments market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.
Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Artificial Tendons and Ligaments market.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/1808
Market Segmentations of the Artificial Tendons and Ligaments Market
This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Artificial Tendons and Ligaments market on the basis of product, application, and region:
Segments Covered in this report are:
Applications Outlook (Revenue, USD Billion; 2019-2032)
Knee injuries
Shoulder injuries
Others
End-use Outlook (Revenue, USD Billion; 2019-2032)
Hospitals
Ambulatory Surgery Centers
Others
Regional Outlook (Revenue, USD Billion; 2019–2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/artificial-tendons-and-ligaments-market
Major Geographies Analyzed in the Report:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
ToC of the report:
Chapter 1: Market overview and scope
Chapter 2: Market outlook
Chapter 3: Impact analysis of COVID-19 pandemic
Chapter 4: Competitive Landscape
Chapter 5: Drivers, Constraints, Opportunities, Limitations
Chapter 6: Key manufacturers of the industry
Chapter 7: Regional analysis
Chapter 8: Market segmentation based on type applications
Chapter 9: Current and Future Trends
Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1808
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Trending Titles: Geocell Market | Pancreatic Cancer Treatment Market
Latest Report: Ceramic Tiles Market | Life Science Analytics Market
0 notes
Photo
The global artificial tendons and ligaments market has the potential to grow by USD 15,546.97 thousand during 2020-2024, and the market’s growth momentum will accelerate throughout the forecast period.
Get Free Sample - http://bit.ly/2Yu6Xx8
#artificial tendons and ligaments market#Global Artificial Tendons and Ligaments Market#Artificial Tendons and Ligaments Market Size#Artificial Tendons and Ligaments Market USA#Artificial Tendons and Ligaments Market 2019
0 notes
Text
U.S. Implantable Medical Devices Market Size Share Trends Forecast 2026
Active medical implants form a significant portion of the overall implants domain. The most common forms of implantable medical devices are prosthetic devices such as artificial organs, defibrillators, reconstructive joints, spinal implants, intraocular implants, breast implants and others. Implantable medical devices serve two major functions namely, application of a therapy from the inside of an organ and monitoring of the parameters and signals of the functioning of an organ for the optimization of treatment.
The U.S. Implantable Medical Devices Market is estimated to account for US$ 86,446.3 Mn in terms of value in 2020 and is expected to reach US$ 150,299.3 Mn by the end of 2027.
U.S. Implantable Medical Devices Market: Drivers
Increasing approval and launch of new products is expected to propel growth of the U.S. implantable medical devices market over the forecast period. For instance, in April 2020, Axonics Modulation Technologies, Inc. received the U.S. Food & Drug Administration approval for its next generation rechargeable implantable neurostimulator for its r-SNM System under a premarket approval supplement.
U.S. Implantable Medical Devices Market: Opportunities:
Use of additively manufactured and commercially pure biomaterials in medical implants is expected to offer lucrative growth opportunities for players in the market. For instance, in April 2020, researchers from University Medical Centre Utrecht, The Netherlands, reported that bony defects treated with additively manufactured commercially pure titanium implants demonstrated higher volumes of regenerated bone as compared to those treated with commonly used titanium alloy.
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/3853
U.S. Implantable Medical Devices Market: Restraints
Increasing recall of products is expected to hinder growth of the market. For instance, in February 2019, Medtronic Plc received FDA product recall for implanted cardiac pacemakers, which affected 13,440 devices manufactured and distributed between March 2017 and January 2019.
Key Takeaways:
The U.S. implantable medical devices market was valued at US$ 79,942.0 Mn in 2019 and is forecast to reach a value of US$ 150,299.3 Mn by 2027 at a CAGR of 8.2% between 2020 and 2027. Factors such as increasing prevalence of cardiovascular and orthopaedic ailments, and developments in implantable medical devices technology
Orthopedic Implants held dominant position in the U.S. implantable medical devices market in 2019, accounting for 51.6% share in terms of value, followed by cardiovascular implants and others, respectively. Increasing prevalence of orthopaedic diseases is expected to support growth of the segment over the forecast period. Moreover, product launches in orthopaedic implants segment is further expected to propel growth of the segment.
Market Trends
R&D in medical implants is expected to aid in growth of the market. For instance, in December 2019, researchers from Tufts University, U.S., reported a novel thermal processing method for the direct solid-state molding of regenerated silk into bulk devices with tunable mechanical properties.
Browse Research Report: https://www.coherentmarketinsights.com/market-insight/us-implantable-medical-devices-market-3853
Orthobiologics are those substances, which are used for quick healing of bone injuries. These materials are highly instrumental in repairing bone injuries and damages to tendons, muscles and ligaments. Orthobiologic products are made of certain substances already present in the human body. The U.S. is viewed as the largest market for orthobiologics, owing to increasing geriatric population
U.S. Implantable Medical Devices Market: Competitive Landscape
Major players operating in the U.S. implantable medical devices market include Abbott Laboratories, Alcon Laboratories, Biomet Incorporated, Bausch and Lomb Incorporated, Boston Scientific Corporation, Johnson and Johnson, Medtronic Incorporated, St. Jude Medical Incorporated, Smith and Nephew PLC, Stryker Corporation, Synthes Incorporated, and Zimmer Holdings Incorporated.
U.S. Implantable Medical Devices Market: Key Developments
April 2020: Exogenesis Corporation established nanoMesh LLC, a new subsidiary focused on commercialization of the Exogenesis Hernia Mesh, an innovative soft tissue repair implant
March 2020: Establishment Labs Holdings Inc. received the U.S. Patent protecting its proprietary breast implant surface technology
Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/3853
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
0 notes
Text
Europe Platelet-rich Plasma Market Analysis (2020-2027)
Autologous platelet-rich plasma (PRP) is a blood plasma concentrate enriched with platelet count above the baseline of whole blood prepared from patient’s own blood. It is used to accelerate the healing of injured tendons, ligaments, muscles and joints.
Europe platelet-rich plasma market is estimated to account for US$ 75.8 Mn in terms of value by the end of 2027.
Europe Platelet-rich Plasma Market: Drivers
Increasing prevalence of musculoskeletal injuries is expected to boost growth of Europe platelet-rich plasma market over the forecast period. For instance, according to the Study, ‘Prevalence of Musculoskeletal Injuries, Pain, and Illnesses in Elite Female Basketball Players, in Europe, in June 2019, the most frequently injured body parts were lower limbs: more than 60%, representing an injury rate of 0.14 per athletes and a 0.2 pain rate per athlete (during the study period).
Moreover, increasing geriatric population and high adoption of knee osteoarthritis treatment in by the age group is also expected to aid in growth of the market. Aging contributes to soft tissue degeneration and related-disorders, particularly of the knee. For instance, according to the study ‘Osteoarthritis in Europe: Impact on health status, work productivity and use of pharmacotherapies in five European countries’ that examined the impact of peripheral joint osteoarthritis across five European countries, UK (43.6%), France, (25.6%), Germany, (15.2%), Spain, (8.4%), and Italy (7.1%) recorded high prevalence of peripheral joint osteoarthritis, with majority of cases aging 55-74 years.
U.K. held dominant position Europe platelet-rich plasma market in 2019, accounting for 23.5% share in terms of valuee, followed by France.
Figure 1. Europe Platelet-rich Plasma Market Value (US$ Mn), by Country/Region, 2019
Europe Platelet-rich Plasma Market: Restraints
Lack of standardization in preparation and dosage of autologous blood concentrate and platelet-separation techniques is a major factor hindering growth of market. Lack of standardization in preparation and dosage of autologous blood concentrate and platelet-separation techniques lead in uncertainty about the evidence to support the increasing clinical use of platelet-rich plasma therapy as a treatment modality for musculoskeletal injuries, including orthopedic bone and soft-tissue injuries.
Moreover, uncertainty about therapeutic efficacy of platelet-rich plasma is also expected to hamper growth of the market. For instance, the study ‘Current Clinical Recommendations for Use of Platelet-Rich Plasma’ published in Current Reviews in Musculoskeletal Medicine in 2018, found moderate high-quality evidence that supported the use of leukocyte-rich (LR)-PRP injection for patellar tendinopathy and of PRP injection for plantar fasciitis and donor site pain in patellar tendon graft Bone-patellar tendon-bone anterior cruciate ligament reconstruction. Moreover, the review also noted insufficient evidence to routinely recommend PRP for rotator cuff tendinopathy, osteoarthritis of the hip, or high ankle sprains.
Europe Platelet-rich Plasma Market: Opportunities
Increasing adoption of PRP in skeletal muscle injuries is expected to offer lucrative growth opportunities for players in the market. PRP has promotes muscle recovery via anabolic growth factors released from activated platelets. This in turn reduces pain, swelling, and time for recovery in skeletal muscle injuries.
Moreover, technological advancements in PRP such as changes in production protocol (time and RPM/centrifugal force) and output level (volume and concentration above baseline) are also expected to aid in growth of the market.
Kits segment in Europe platelet-rich plasma market was valued at US$ 34.9 Mn in 2019 and is expected to reach US$ 60.4 by 2027 at a CAGR of 7.1% during the forecast period.
Market Trends/Key Takeaways
The demand for pure PRP fibrin therapy has increased significantly in the recent past, especially for the treatment of skin wound ulcers and in oral and maxillofacial surgeries. The platelet-rich fibrin therapy is classified as a second generation platelet concentrate, with rich platelet content and extensive growth factors in the form of fibrin membranes, which are free of any anti-coagulants or other artificial bio-chemical modifications and promote rapid and accelerated wound healing.
Increasing geriatric population in Europe has led to high demand for non-invasive or minimally invasive surgical treatments. PRP therapy is a simple, efficient, and minimally invasive procedure that represents an appropriate biological approach for ensuring tissue regeneration in a very short period of time. Such scenario has led to high adoption of PRP therapy for the treatment of orthopedic related injuries in geriatric patients.
Regulations
Europe
· Directive 2002/98/EC of the European Parliament and Council of January 27, 2003, regulates the approval process for blood and blood-derived products
o This committee is engaged in the establishment of quality, safety, and efficacy of blood products and in setting norms for collection, processing, and distribution of blood components across the European Union countries
· Harmonized regulatory framework for PRP therapies is not present
o Each country has its own approach to PRP regulation within the jurisdiction of national authorities
· Devices must comply with Class II- medical device directive 93/42/EEC.
o Device approval is overseen in each EU country by a governmental body called a ‘Competent Authority.’
o The surgical use of PRP can be considered as an autologous graft within the surgical procedure as regulated by Directive 2004/23/EC
Europe Platelet-rich Plasma Market: Competitive Landscape
Major players operating in Europe include, Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., and Estar Technologies Ltd.
Europe Platelet-rich Plasma Market: Key Developments
In January 2020, SHVI PRP Therapy, announced a new website that is focused specifically at the use of PRP to mitigate hair loss.
In March 2019, CollPlant, a regenerative medicine company, renewed its exclusive distribution agreement with Arthrex for Vergenix STR, an injectable gel comprised of cross-linked bioengineered recombinant human type I collagen, rhCollagen, combined with autologous PRP, for the treatment of tendinopathy.
In January 2019, Generex Biotechnology Corporation entered into a letter of intent to acquire Medisource Partners, an FDA-registered distributor of medical and surgical products including supplies kits to process bone marrow aspirates and PRP biologics at the time of surgery.
In December 2018, Regenexx’s research published in the Journal of Translational Medicine, which involved use of patients' own bone marrow concentrate and PRP products demonstrated positive clinical outcomes for the treatment of osteoarthritis of the knee.
Request sample copy here :
https://www.coherentmarketinsights.com/insight/request-sample/3346
Request PDF brochure here:
https://www.coherentmarketinsights.com/insight/request-pdf/3346
Click here to buy: https://www.coherentmarketinsights.com/insight/buy-now/3346
CMI Services: https://www.coherentmarketinsights.com/services
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.
What we provide:
· Customized Market Research Services
· Industry Analysis Services
· Business Consulting Services
· Market Intelligence Services
· Long term Engagement Model
· Country Specific Analysis
Contact Us:
Mr. Shah
Coherent Market Insights Pvt. Ltd.
Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.
Phone: +1-206-701-6702
Email : [email protected]
Reference/Source: https://www.coherentmarketinsights.com/market-insight/europe-platelet-rich-plasma-market-3346
#EuropePlateletrichPlasmaMarketAnalysis#bloodplasmaconcentrate#plateletcount#Healthcare#MarketAnalysis#CoherentMarketInsights
0 notes
Text
EUROPE PLATELET-RICH PLASMA MARKET ANALYSIS
Autologous platelet-rich plasma (PRP) is a blood plasma concentrate enriched with platelet count above the baseline of whole blood prepared from patient’s own blood. It is used to accelerate the healing of injured tendons, ligaments, muscles and joints.
Europe platelet-rich plasma market is estimated to account for US$ 75.8 Mn in terms of value by the end of 2027.
Europe Platelet-rich Plasma Market: Drivers
Increasing prevalence of musculoskeletal injuries is expected to boost growth of Europe platelet-rich plasma market over the forecast period. For instance, according to the Study, ‘Prevalence of Musculoskeletal Injuries, Pain, and Illnesses in Elite Female Basketball Players, in Europe, in June 2019, the most frequently injured body parts were lower limbs: more than 60%, representing an injury rate of 0.14 per athletes and a 0.2 pain rate per athlete (during the study period).
Moreover, increasing geriatric population and high adoption of knee osteoarthritis treatment in by the age group is also expected to aid in growth of the market. Aging contributes to soft tissue degeneration and related-disorders, particularly of the knee. For instance, according to the study ‘Osteoarthritis in Europe: Impact on health status, work productivity and use of pharmacotherapies in five European countries’ that examined the impact of peripheral joint osteoarthritis across five European countries, UK (43.6%), France, (25.6%), Germany, (15.2%), Spain, (8.4%), and Italy (7.1%) recorded high prevalence of peripheral joint osteoarthritis, with majority of cases aging 55-74 years.
U.K. held dominant position Europe platelet-rich plasma market in 2019, accounting for 23.5% share in terms of valuee, followed by France.
Figure 1. Europe Platelet-rich Plasma Market Value (US$ Mn), by Country/Region, 2019
Europe Platelet-rich Plasma Market: Restraints
Lack of standardization in preparation and dosage of autologous blood concentrate and platelet-separation techniques is a major factor hindering growth of market. Lack of standardization in preparation and dosage of autologous blood concentrate and platelet-separation techniques lead in uncertainty about the evidence to support the increasing clinical use of platelet-rich plasma therapy as a treatment modality for musculoskeletal injuries, including orthopedic bone and soft-tissue injuries.
Moreover, uncertainty about therapeutic efficacy of platelet-rich plasma is also expected to hamper growth of the market. For instance, the study ‘Current Clinical Recommendations for Use of Platelet-Rich Plasma’ published in Current Reviews in Musculoskeletal Medicine in 2018, found moderate high-quality evidence that supported the use of leukocyte-rich (LR)-PRP injection for patellar tendinopathy and of PRP injection for plantar fasciitis and donor site pain in patellar tendon graft Bone-patellar tendon-bone anterior cruciate ligament reconstruction. Moreover, the review also noted insufficient evidence to routinely recommend PRP for rotator cuff tendinopathy, osteoarthritis of the hip, or high ankle sprains.
Europe Platelet-rich Plasma Market: Opportunities
Increasing adoption of PRP in skeletal muscle injuries is expected to offer lucrative growth opportunities for players in the market. PRP has promotes muscle recovery via anabolic growth factors released from activated platelets. This in turn reduces pain, swelling, and time for recovery in skeletal muscle injuries.
Moreover, technological advancements in PRP such as changes in production protocol (time and RPM/centrifugal force) and output level (volume and concentration above baseline) are also expected to aid in growth of the market.
Kits segment in Europe platelet-rich plasma market was valued at US$ 34.9 Mn in 2019 and is expected to reach US$ 60.4 by 2027 at a CAGR of 7.1% during the forecast period.
Market Trends/Key Takeaways
The demand for pure PRP fibrin therapy has increased significantly in the recent past, especially for the treatment of skin wound ulcers and in oral and maxillofacial surgeries. The platelet-rich fibrin therapy is classified as a second generation platelet concentrate, with rich platelet content and extensive growth factors in the form of fibrin membranes, which are free of any anti-coagulants or other artificial bio-chemical modifications and promote rapid and accelerated wound healing.
Increasing geriatric population in Europe has led to high demand for non-invasive or minimally invasive surgical treatments. PRP therapy is a simple, efficient, and minimally invasive procedure that represents an appropriate biological approach for ensuring tissue regeneration in a very short period of time. Such scenario has led to high adoption of PRP therapy for the treatment of orthopedic related injuries in geriatric patients.
Regulations
Europe
Directive 2002/98/EC of the European Parliament and Council of January 27, 2003, regulates the approval process for blood and blood-derived products
Harmonized regulatory framework for PRP therapies is not present
Devices must comply with Class II- medical device directive 93/42/EEC.
This committee is engaged in the establishment of quality, safety, and efficacy of blood products and in setting norms for collection, processing, and distribution of blood components across the European Union countries
Each country has its own approach to PRP regulation within the jurisdiction of national authorities
Device approval is overseen in each EU country by a governmental body called a ‘Competent Authority.’
The surgical use of PRP can be considered as an autologous graft within the surgical procedure as regulated by Directive 2004/23/EC
Europe Platelet-rich Plasma Market: Competitive Landscape
Major players operating in Europe include, Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., and Estar Technologies Ltd.
Europe Platelet-rich Plasma Market: Key Developments
In January 2020, SHVI PRP Therapy, announced a new website that is focused specifically at the use of PRP to mitigate hair loss.
In March 2019, CollPlant, a regenerative medicine company, renewed its exclusive distribution agreement with Arthrex for Vergenix STR, an injectable gel comprised of cross-linked bioengineered recombinant human type I collagen, rhCollagen, combined with autologous PRP, for the treatment of tendinopathy.
In January 2019, Generex Biotechnology Corporation entered into a letter of intent to acquire Medisource Partners, an FDA-registered distributor of medical and surgical products including supplies kits to process bone marrow aspirates and PRP biologics at the time of surgery.
In December 2018, Regenexx’s research published in the Journal of Translational Medicine, which involved use of patients' own bone marrow concentrate and PRP products demonstrated positive clinical outcomes for the treatment of osteoarthritis of the knee.
About Us- Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: Customized Market Research Services Industry Analysis Services Business Consulting Services Market Intelligence Services Long term Engagement Model Country Specific Analysis Mr. Shah
Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1–206–701��6702 Email: [email protected]
#EUROPE PLATELET-RICH PLASMA MARKET ANALYSIS#platelet-rich plasma#platelet-rich plasma market analysis#europe market analysis
0 notes
Photo
Artificial Tendons and Ligaments Market: Industry Size, Share, Trends, Analysis Report and Forecast 2019 - 2027. For more info: https://meridianmarketconsultants.com/artificial-tendons-and-ligaments-market
#Artificial Tendons and Ligaments Market Report#USA Artificial Tendons and Ligaments Market#Artificial Tendons and Ligaments Market News#MEA Artificial Tendons and Ligaments Market#Healthcare market report#Health management market report
0 notes
Text
Artificial Tendons and Ligaments Market Explores New Growth Opportunities - MMC 2019-2027
Global Artificial Tendons and Ligaments Market, by Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries, and Others), by End-use (Hospitals & Clinics and Ambulatory Surgery Centres) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2019 and 2027.
For requesting free sample related to our latest study on Global Artificial Tendons and Ligaments Market, Visit : https://meridianmarketconsultants.com/requst?rid=3589
As per the report, the artificial tendons and ligaments market is driven by factors like increasing incidences of sports injuries, numerous on-going R & D activities on artificial tendons and ligaments coupled with the adoption of minimally invasive surgeries. Numerous cases of knee trauma and its significance in daily life along with the changing infrastructure and the presence of specialty hospitals across all globe also boost the demand for artificial tendons and ligaments. Furthermore, the obtainability of a large patient pool with the availability of skilled personnel for performing minimally invasive orthopedic procedures also propels the growth of artificial tendons and ligaments market. Increasing healthcare expenditure, rising consumer awareness and the high purchasing power of the elderly patients also anticipate the market growth during the forecast years.
The innovation of tissue-engineered ligaments aimed at reducing the necessity for ligament grafting procedures. This not only minimizes the risk of rejection and tissue mismatch; but also aims in elevating the demand for artificial tendons and ligaments, thereby resulting in market growth. However, the excessive cost of surgical procedures coupled with the limited reimbursements restrict the market growth. Additionally, the rising count of orthopedic reconstructive injuries may also retard the demand for artificial tendons and ligaments during the next decade. Moreover, the ongoing research and development activities on tissue-engineered ligament along with the invention of 3D printing human ligament and tendons serve to be the latest and updated market trends promising the market growth.
To know the latest insights, qualitative data, trends, quantitative data, and more related to Global Artificial Tendons and Ligaments Market, visit: https://meridianmarketconsultants.com/artificial-tendons-and-ligaments-market
Furthermore, Meridian Market Consultants (MMC) Study identifies that the market growth opportunities are propelled by the technological advances in this field with the increasing demand and expansion increasing from the developing market. The diverging focus on the biomechanical investigation of tendons and ligaments in the market driving trend; whereas, the lack of skilled personnel and the growing competition among the key players in the major challenge for artificial tendons and ligaments market.
MMC Study identifies some of the key participating players in ARTIFICIAL TENDONS AND LIGAMENTS market globally are Artelon, Corin, Cousin Biotech, FH Orthopedics, FX Solutions S.A.S., LARS, Mathys AG Bettlach, Neoligaments, Orthomed S.A.S, Shanghai Pine & Power Biotech Co., Ltd., and Xiros Ltd.
Read Detail News @ : https://meridianmarketconsultants.com/pressrelese/artificial-tendons-and-ligaments-market
About Meridian Market Consultants:
Meridian Market Consultants (MMC) is committed to provide deep insights that serve as a creative tool for the client that enables it to perform confidently in the market. At MMC we adhere to the client's needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
Contact Us:
Meridian Market Consultants (MMC)
13121, Louetta Road,
#440, Cypress, Texas 77429
United States
Tel: +1-(281)-619-8646
For Sales Queries: [email protected]
#Artificial Tendons and Ligaments Market#Artificial Tendons and Ligaments Market report#market forecast#market shares#Artificial Tendons and Ligaments Market mgmt#Artificial Tendons and Ligaments Market research report#market analysis#business analysis
0 notes
Link
0 notes
Text
Overview of Artificial Tendons and Ligaments: Understanding the Basics
The global artificial tendons and ligaments market size reached USD 1.86 Billion in 2022 and is expected to register a revenue CAGR of 13.6% during the forecast period, according to latest analysis by Emergen Research. Sports-related injuries are becoming ever-more common, and this is a key factor driving market revenue growth. Rise in medical expenditure is also being driven by the increasing number of traffic accidents in various countries around the world.
The global Artificial Tendons and Ligaments market report is a methodical research of the Artificial Tendons and Ligaments market done by extensive primary and secondary research. The fundamental purpose of the Artificial Tendons and Ligaments market report is to offer an accurate and strategic analysis of the Artificial Tendons and Ligaments business sphere.
Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/1808
Competitive Terrain:
The global Artificial Tendons and Ligaments industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.
The leading market contenders listed in the report are:
Neoligaments; Orthomed S.A.S.; Corin Group; Arthrex Inc.; HLL Lifecare Limited; Mathys AG Bettlach; FH Orthopedics
Key market aspects studied in the report:
Market Scope: The report explains the scope of various commercial possibilities in the global Artificial Tendons and Ligaments market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.
Competitive Outlook: The leading companies operating in the Artificial Tendons and Ligaments market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.
Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Artificial Tendons and Ligaments market.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/1808
Market Segmentations of the Artificial Tendons and Ligaments Market
This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Artificial Tendons and Ligaments market on the basis of product, application, and region:
Segments Covered in this report are:
Applications Outlook (Revenue, USD Billion; 2019-2032)
Knee injuries
Shoulder injuries
Others
End-use Outlook (Revenue, USD Billion; 2019-2032)
Hospitals
Ambulatory Surgery Centers
Others
Regional Outlook (Revenue, USD Billion; 2019–2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/artificial-tendons-and-ligaments-market
Major Geographies Analyzed in the Report:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
ToC of the report:
Chapter 1: Market overview and scope
Chapter 2: Market outlook
Chapter 3: Impact analysis of COVID-19 pandemic
Chapter 4: Competitive Landscape
Chapter 5: Drivers, Constraints, Opportunities, Limitations
Chapter 6: Key manufacturers of the industry
Chapter 7: Regional analysis
Chapter 8: Market segmentation based on type applications
Chapter 9: Current and Future Trends
Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1808
0 notes
Link
Dec 20, 2019 (The Expresswire) -- The report firstly introduced the Artificial Ligaments and Tendons basics: definitions, classifications, applications and...
0 notes
Text
Artificial Tendons & Ligaments Market Size, Industry Trends, Regional Outlook, Company Share and Segment Forecasts 2019 - 2025
Artificial Tendons & Ligaments Market Size, Industry Trends, Regional Outlook, Company Share and Segment Forecasts 2019 – 2025
The global artificial tendons and ligaments market size is anticipated to reach USD 39.7 million by 2025 at an 11.3% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Adoption of artificial grafts is on a rise owing to several benefits over autologous and allogenic grafts, such as high tensile strength, no immune reaction, and abrasion resistance. Increase in…
View On WordPress
0 notes
Text
3D Medical Imaging Global Market- Industry Analysis, Size, Share, Growth, Trends and Forecast 2020-2026
Summary – A new market study, titled " 3D Medical Imaging Global Market- Industry Analysis, Size, Share, Growth, Trends and Forecast 2020-2026 " has been featured on WiseGuyReports.
3D Medical Imaging Global Market Report 2020: Covid 19 Growth And Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global 3d medical imaging market.
This report focuses on 3d medical imaging market which is experiencing strong growth. The report gives a guide to the 3d medical imaging market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.
Also read – https://www.medgadget.com/2020/06/global-3d-medical-imaging-market-2020-covid-19-impact-share-trend-segmentation-and-forecast-to-2026.html
Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the 3d medical imaging? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The 3D Medical Imaging global market report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider 3d medical imaging market, and compares it with other markets.
• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
• Market segmentations break down market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
• Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
• The 3d medical imaging market section of the report gives context. It compares the 3d medical imaging market with other segments of the 3d medical imaging market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, 3d medical imaging indicators comparison.
Scope
Markets Covered: 1) By Type: Ultrasound; X-ray; CT Scan; Others
2) By End User: Diagnostic Centers; Hospitals; Research Centers
3) By Application: Gynecology and Obstetrics; Cardiology; Neurology; Orthopedics; Oncology
Companies Mentioned: GE Healthcare; Royal Philips; Siemens AG; The Esaote Group; Intrasense SA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Major players in the 3D medical imaging market are GE Healthcare, Royal Philips, Siemens AG, The Esaote Group, and Intrasense SA.
The global 3D medical imaging market is expected decline from $14.3 billion in 2019 and to $13.67 billion in 2020 at a compound annual growth rate (CAGR) of -4.4%. The decline is mainly due to economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and reach $16.93 billion in 2023 at CAGR of 7.4%.
The 3D medical imaging market consists of sales of 3D Ultrasound, X-Ray, CT scan, MRI, Hybrid Imaging equipment and related services. 3D medical imaging is used to create three dimensions’ visual representation of interior body parts for medical analysis with the help of computer-aided design (CAD) or a Magnetic Resonance Image (MRI).
3D medical imaging device manufacturers are increasingly investing in Artificial Intelligence (AI) to improve the diagnosis by giving accurate, hard-number measurements. AI provides efficiency in medical imaging, particularly when it comes to detecting organs or anomalies. For instance, by combining image visualization and AI, cardiologists can measure ejection fraction with high precision and in a much shorter period of time. Ejection fraction is a measurement of the percentage of blood leaving the heart each time when it contracts. According to a report by Signify Research, in January 2019, capital investments in startup companies developing 3D medical imaging AI solutions reached almost $580 million in 2018 from $270 million in 2017.
The 3D medical imaging market covered in this report is segmented by type into ultrasound, X-ray, CT scan, others. It is also segmented by end user into diagnostic centers, hospitals, research centers and by application into gynecology and obstetrics, cardiology, neurology, orthopedics, oncology.
The difficulties faced by the medical device industry owing to the COVID-19 outbreak such as the slowdown in orders and supply chain disruptions are likely to restraint the growth of the 3D medical imaging market over the next coming years. According to Medical Products Outsourcing (MPO) magazine published in April 2020, financial strains and supply chain disruptions are the major challenges faced by the medical devices industry. The manufactures are experiencing a modest slowdown in orders attributing to tight management of inventories due to fear of the spread of the virus and slow pace of reorders owing to the impact of the virus on businesses. Moreover, the managers are also hesitant in overseeing the new product launches in uncertain times. This scenario is predicted to act as a major factor restraining the growth of the market in the near future.
In June 2018, Philips acquired EPD solutions Ltd. for $0.29 billion. With this acquisition, EPD Solutions Ltd., operates as a subsidiary of Philips. This acquisition helped Philips to improve the image-guided treatment of cardiac arrhythmias by pinpointing the location and orientation of catheters during the diagnostic and therapeutic procedures. EPD Solutions Ltd. develops cardiac imaging and navigation systems for patients with heart rhythm disorders.
Increasing cases of injuries such as sports-related injuries contribute to the growth of the 3D medical imaging market. The increase in sports-related injuries is due to increasing participation of individuals in organized and unorganized sports activities. Moreover, the training of athletes with high strength and high load also results in more and more serious injuries. Sports injuries are mainly characterized by soft tissue injury. The use of 3D medical imaging devices such as ultrasound diagnosis, X-ray radiography, MRI imaging provides an accurate and objective basis for the diagnosis. The 3D medical imaging devices help in the examination of muscle fascia injury, tendon injury, ligament injury, meniscus injury, articular cartilage, and bone fracture. According to the Centre for the Disease Control and Prevention, in 2017, it is estimated that there are 775,000 emergency room visits due to the injuries in children who are participating in the unorganized and organized sports activities. Thus, increase in demand for 3D medical imaging devices, favoring the market growth.
For more details - https://www.wiseguyreports.com/reports/5358015-3d-medical-imaging-global-market-report-2020-30
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +162-825-80070 (US)
Ph: +44 2035002763 (UK)
0 notes
Text
Europe Platelet rich Plasma Market Share, Outlook, and Opportunity Analysis, 2020 – 2027
Autologous platelet-rich plasma (PRP) is a blood plasma concentrate enriched with platelet count above the baseline of whole blood prepared from patient’s own blood. It is used to accelerate the healing of injured tendons, ligaments, muscles and joints.Europe platelet-rich plasma market is estimated to account for US$ 75.8 Mn in terms of value by the end of 2027.
Request a sample copy of this report:- https://www.coherentmarketinsights.com/insight/request-sample/3346
Increasing prevalence of musculoskeletal injuries is expected to boost growth of Europe platelet-rich plasma market over the forecast period. For instance, according to the Study, ‘Prevalence of Musculoskeletal Injuries, Pain, and Illnesses in Elite Female Basketball Players, in Europe, in June 2019, the most frequently injured body parts were lower limbs: more than 60%, representing an injury rate of 0.14 per athletes and a 0.2 pain rate per athlete (during the study period).
U.K. held dominant position Europe platelet-rich plasma market in 2019, accounting for 23.5% share in terms of valuee, followed by France.Lack of standardization in preparation and dosage of autologous blood concentrate and platelet-separation techniques is a major factor hindering growth of market. Lack of standardization in preparation and dosage of autologous blood concentrate and platelet-separation techniques lead in uncertainty about the evidence to support the increasing clinical use of platelet-rich plasma therapy as a treatment modality for musculoskeletal injuries, including orthopedic bone and soft-tissue injuries.
Moreover, uncertainty about therapeutic efficacy of platelet-rich plasma is also expected to hamper growth of the market. For instance, the study ‘Current Clinical Recommendations for Use of Platelet-Rich Plasma’ published in Current Reviews in Musculoskeletal Medicine in 2018, found moderate high-quality evidence that supported the use of leukocyte-rich (LR)-PRP injection for patellar tendinopathy and of PRP injection for plantar fasciitis and donor site pain in patellar tendon graft Bone-patellar tendon-bone anterior cruciate ligament reconstruction. Moreover, the review also noted insufficient evidence to routinely recommend PRP for rotator cuff tendinopathy, osteoarthritis of the hip, or high ankle sprains.
Increasing adoption of PRP in skeletal muscle injuries is expected to offer lucrative growth opportunities for players in the market. PRP has promotes muscle recovery via anabolic growth factors released from activated platelets. This in turn reduces pain, swelling, and time for recovery in skeletal muscle injuries.
Moreover, technological advancements in PRP such as changes in production protocol (time and RPM/centrifugal force) and output level (volume and concentration above baseline) are also expected to aid in growth of the market.Kits segment in Europe platelet-rich plasma market was valued at US$ 34.9 Mn in 2019 and is expected to reach US$ 60.4 by 2027 at a CAGR of 7.1% during the forecast period.
The demand for pure PRP fibrin therapy has increased significantly in the recent past, especially for the treatment of skin wound ulcers and in oral and maxillofacial surgeries. The platelet-rich fibrin therapy is classified as a second generation platelet concentrate, with rich platelet content and extensive growth factors in the form of fibrin membranes, which are free of any anti-coagulants or other artificial bio-chemical modifications and promote rapid and accelerated wound healing.
Increasing geriatric population in Europe has led to high demand for non-invasive or minimally invasive surgical treatments. PRP therapy is a simple, efficient, and minimally invasive procedure that represents an appropriate biological approach for ensuring tissue regeneration in a very short period of time. Such scenario has led to high adoption of PRP therapy for the treatment of orthopedic related injuries in geriatric patients.
Major players operating in Europe include, Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., and Estar Technologies Ltd.
Get the main link:- https://www.coherentmarketinsights.com/market-insight/europe-platelet-rich-plasma-market-3346
Contact Us:
Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] Visit our news Website: http://www.coherentchronicle.com/
0 notes
Text
Artificial Tendons and Ligaments Market: Industry Size, Share, Trends, Analysis Report and Forecast 2019 - 2027
Global Artificial Tendons and Ligaments Market, by Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries, and Others), by End-use (Hospitals & Clinics and Ambulatory Surgery Centres) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2019 and 2027.
For requesting free sample our latest study on Global Artificial Tendons and Ligaments Market, visit: https://meridianmarketconsultants.com/requst?rid=3589
As per the report, the artificial tendons and ligaments market is driven by factors like increasing incidences of sports injuries, numerous on-going R & D activities on artificial tendons and ligaments coupled with the adoption of minimally invasive surgeries. Numerous cases of knee trauma and its significance in daily life along with the changing infrastructure and the presence of specialty hospitals across all globe also boost the demand for artificial tendons and ligaments. Furthermore, the obtainability of a large patient pool with the availability of skilled personnel for performing minimally invasive orthopedic procedures also propels the growth of artificial tendons and ligaments market. Increasing healthcare expenditure, rising consumer awareness and the high purchasing power of the elderly patients also anticipate the market growth during the forecast years.
The innovation of tissue-engineered ligaments aimed at reducing the necessity for ligament grafting procedures. This not only minimizes the risk of rejection and tissue mismatch; but also aims in elevating the demand for artificial tendons and ligaments, thereby resulting in market growth. However, the excessive cost of surgical procedures coupled with the limited reimbursements restrict the market growth. Additionally, the rising count of orthopedic reconstructive injuries may also retard the demand for artificial tendons and ligaments during the next decade. Moreover, the ongoing research and development activities on tissue-engineered ligament along with the invention of 3D printing human ligament and tendons serve to be the latest and updated market trends promising the market growth.
To know the latest insights, qualitative data, trends, quantitative data, and more related to Global Artificial Tendons and Ligaments Market, visit: https://meridianmarketconsultants.com/artificial-tendons-and-ligaments-market
Furthermore, Meridian Market Consultants (MMC) Study identifies that the market growth opportunities are propelled by the technological advances in this field with the increasing demand and expansion increasing from the developing market. The diverging focus on the biomechanical investigation of tendons and ligaments in the market driving trend; whereas, the lack of skilled personnel and the growing competition among the key players in the major challenge for artificial tendons and ligaments market.
For more info: https://meridianmarketconsultants.com/pressrelese/artificial-tendons-and-ligaments-market
MMC Study identifies some of the key participating players in ARTIFICIAL TENDONS AND LIGAMENTS market globally are Artelon, Corin, Cousin Biotech, FH Orthopedics, FX Solutions S.A.S., LARS, Mathys AG Bettlach, Neoligaments, Orthomed S.A.S, Shanghai Pine & Power Biotech Co., Ltd., and Xiros Ltd.
About Meridian Market Consultants:
Meridian Market Consultants (MMC) is committed to provide deep insights that serve as a creative tool for the client that enables it to perform confidently in the market. At MMC we adhere to the client's needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
Contact Us:
Meridian Market Consultants (MMC)
13121, Louetta Road,
#440, Cypress, Texas 77429
United States
Tel: +1-(281)-619-8646
For Sales Queries: [email protected]
#Artificial Tendons and Ligaments Market Report#USA Artificial Tendons and Ligaments Market#Artificial Tendons and Ligaments Market News#Healthcare market report#MEA Artificial Tendons and Ligaments Market#Health management market report
0 notes
Text
Artificial Tendons &: Ligaments Market: Global Industry Growth, Size, Demand, Trends, Insights and Future Prospect 2020-27
Global Artificial Tendons and Ligaments Market, by Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries, and Others), by End-use (Hospitals & Clinics and Ambulatory Surgery Centres) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2019 and 2027.
For requesting free sample latest study on Global Artificial Tendons and Ligaments Market, Visit: https://meridianmarketconsultants.com/requst?rid=3589
As per the report, the artificial tendons and ligaments market is driven by factors like increasing incidences of sports injuries, numerous on-going R & D activities on artificial tendons and ligaments coupled with the adoption of minimally invasive surgeries. Numerous cases of knee trauma and its significance in daily life along with the changing infrastructure and the presence of specialty hospitals across all globe also boost the demand for artificial tendons and ligaments. Furthermore, the obtainability of a large patient pool with the availability of skilled personnel for performing minimally invasive orthopedic procedures also propels the growth of artificial tendons and ligaments market. Increasing healthcare expenditure, rising consumer awareness and the high purchasing power of the elderly patients also anticipate the market growth during the forecast years.
The innovation of tissue-engineered ligaments aimed at reducing the necessity for ligament grafting procedures. This not only minimizes the risk of rejection and tissue mismatch; but also aims in elevating the demand for artificial tendons and ligaments, thereby resulting in market growth. However, the excessive cost of surgical procedures coupled with the limited reimbursements restrict the market growth. Additionally, the rising count of orthopedic reconstructive injuries may also retard the demand for artificial tendons and ligaments during the next decade. Moreover, the ongoing research and development activities on tissue-engineered ligament along with the invention of 3D printing human ligament and tendons serve to be the latest and updated market trends promising the market growth.
To know the latest insights, qualitative data, trends, quantitative data, and more related to Global Artificial Tendons and Ligaments Market, Visit: https://meridianmarketconsultants.com/artificial-tendons-and-ligaments-market
Furthermore, Meridian Market Consultants (MMC) Study identifies that the market growth opportunities are propelled by the technological advances in this field with the increasing demand and expansion increasing from the developing market. The diverging focus on the biomechanical investigation of tendons and ligaments in the market driving trend; whereas, the lack of skilled personnel and the growing competition among the key players in the major challenge for artificial tendons and ligaments market.
For more info: https://meridianmarketconsultants.com/pressrelese/artificial-tendons-and-ligaments-market
MMC Study identifies some of the key participating players in ARTIFICIAL TENDONS AND LIGAMENTS market globally are Artelon, Corin, Cousin Biotech, FH Orthopedics, FX Solutions S.A.S., LARS, Mathys AG Bettlach, Neoligaments, Orthomed S.A.S, Shanghai Pine & Power Biotech Co., Ltd., and Xiros Ltd.
About Meridian Market Consultants:
Meridian Market Consultants (MMC) is committed to provide deep insights that serve as a creative tool for the client that enables it to perform confidently in the market. At MMC we adhere to the client's needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
Contact Us:
Meridian Market Consultants (MMC)
13121, Louetta Road,
#440, Cypress, Texas 77429
United States
Tel: +1-(281)-619-8646
For Sales Queries: [email protected]
#Artificial Tendons & Ligaments Market Report#USA Artificial Tendons & Ligaments Market#Artificial Tendons & Ligaments Market News#MEA Artificial Tendons & Ligaments Market#Healthcare market report
0 notes
Text
Artificial Tendons and Ligaments Market Outline, Surge and Forecast by Key Players 2027
Global Artificial Tendons and Ligaments Market, by Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries, and Others), by End-use (Hospitals & Clinics and Ambulatory Surgery Centres) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2019 and 2027.
For requesting free sample related to our latest study on Global Artificial Tendons and Ligaments Market, For visit: https://meridianmarketconsultants.com/requst?rid=3589
As per the report, the artificial tendons and ligaments market is driven by factors like increasing incidences of sports injuries, numerous on-going R & D activities on artificial tendons and ligaments coupled with the adoption of minimally invasive surgeries. Numerous cases of knee trauma and its significance in daily life along with the changing infrastructure and the presence of specialty hospitals across all globe also boost the demand for artificial tendons and ligaments. Furthermore, the obtainability of a large patient pool with the availability of skilled personnel for performing minimally invasive orthopedic procedures also propels the growth of artificial tendons and ligaments market. Increasing healthcare expenditure, rising consumer awareness and the high purchasing power of the elderly patients also anticipate the market growth during the forecast years.
The innovation of tissue-engineered ligaments aimed at reducing the necessity for ligament grafting procedures. This not only minimizes the risk of rejection and tissue mismatch; but also aims in elevating the demand for artificial tendons and ligaments, thereby resulting in market growth. However, the excessive cost of surgical procedures coupled with the limited reimbursements restrict the market growth. Additionally, the rising count of orthopedic reconstructive injuries may also retard the demand for artificial tendons and ligaments during the next decade. Moreover, the ongoing research and development activities on tissue-engineered ligament along with the invention of 3D printing human ligament and tendons serve to be the latest and updated market trends promising the market growth.
To know the latest insights, qualitative data, trends, quantitative data, and more related to Global Artificial Tendons and Ligaments Market, For visit: https://meridianmarketconsultants.com/artificial-tendons-and-ligaments-market
Furthermore, Meridian Market Consultants (MMC) Study identifies that the market growth opportunities are propelled by the technological advances in this field with the increasing demand and expansion increasing from the developing market. The diverging focus on the biomechanical investigation of tendons and ligaments in the market driving trend; whereas, the lack of skilled personnel and the growing competition among the key players in the major challenge for artificial tendons and ligaments market.
MMC Study identifies some of the key participating players in ARTIFICIAL TENDONS AND LIGAMENTS market globally are Artelon, Corin, Cousin Biotech, FH Orthopedics, FX Solutions S.A.S., LARS, Mathys AG Bettlach, Neoligaments, Orthomed S.A.S, Shanghai Pine & Power Biotech Co., Ltd., and Xiros Ltd.
Artificial Tendons and Ligaments Market, For more inquiry: https://meridianmarketconsultants.com/pressrelese/artificial-tendons-and-ligaments-market
About Meridian Market Consultants:
Meridian Market Consultants (MMC) is committed to provide deep insights that serve as a creative tool for the client that enables it to perform confidently in the market. At MMC we adhere to the client's needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
Contact Us:
Meridian Market Consultants (MMC)
13121, Louetta Road,
#440, Cypress, Texas 77429
United States
Tel: +1-(281)-619-8646
For Sales Queries: [email protected]
#Artificial Tendons and Ligaments Market#Artificial Tendons and Ligaments Market Analysis#Artificial Tendons and Ligaments Market Trends#Artificial Tendons and Ligaments Market NEws
0 notes